VanEck Associates’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-766	Closed	-$93K	–	702
2014 Q2	$93K	Buy	766 +154	+25%	+$18.7K	﹤0.01%	682
2014 Q1	$78K	Buy	612 +127	+26%	+$16.2K	﹤0.01%	665
2013 Q4	$61K	Buy	+485	New	+$61K	﹤0.01%	658